Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Life events or new priorities often require tweaks; identify triggers and implement targeted changes to keep your finances on track.
19,621 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Mozilla’s latest security push uses Mythos AI to slash a year of fixes into one month, highlighting how AI-assisted d...
A Virginia federal judge denied Zillow and Redfin’s bid to dismiss the FTC antitrust lawsuit, keeping the case alive ...
Brent crude charts flashed a pattern not seen in 36 years, triggering fresh volatility bets. Analysts say the rarity ...
As Insight (NSIT) reports Q1 2026 results, investors seek clarity on revenue drivers and margins. This guide breaks d...
Emcor Group combines breadth in facilities management and electrical/mechanical contracting with a steady financial p...
Mega-IPOs grab headlines, but what sticks after the first week? This article breaks down the five biggest IPOs in his...
Housing costs and fuel prices are digitizing the inflation picture. This article explains how shelter gasoline pushed...
MercadoLibre reports a robust Q1 2026 with revenue rising sharply, even as margins compress. Analysts increasingly vi...
Cerebras burst onto the public market with a splashy IPO, but a strong first day doesn’t guarantee long-term gains. T...
A surge in AI infrastructure chips has lifted the Philadelphia Semiconductor Index, yet broad market participation is...
US-listed Bitcoin ETFs posted a $1 billion weekly outflow, ending a six-week streak of inflows as inflation jitters w...